BioCorneum®, classified by the FDA under a 510(k) as a medical device, manages old and new scars, and prevents the formation of keloids, hypertrophic and atrophic scars resulting from surgery, trauma, burns and skin infections. When applied to the affected area, it suppresses growth factors that lead to scarring, while protecting tissue against physical, chemical and microbial invasion. BioCorneum® rapidly self-dries, offering patients a discreet, effective and convenient way to treat scars.
Accoring to CAraMedica representatives, this product line will bring dramatic and sustained growth for the company, considering the booming cosmetic surgery industry. A spray version of the product will be released later this year.
[Source: PR.com]
Comment Preview